Sign in

    Josh Waldman

    Senior Analyst specializing in equity research at Cleveland Research Company

    Josh Waldman is a Senior Analyst specializing in equity research at Cleveland Research Company, with a focus on covering leading life sciences and diagnostics firms such as Waters Corporation, Agilent Technologies, and Charles River Laboratories. He is recognized for his targeted coverage within the healthcare and laboratory services sectors, contributing research used in investor relations for major companies like Waters and Agilent, and has actively participated in earnings calls for Charles River. Waldman’s career at Cleveland Research has involved deep dive analysis in pharma and diagnostics since at least the late 2010s, and his expertise is frequently highlighted in major industry forums and investor resources. He holds senior credentials in equity research, though specific performance metrics and securities licenses are not publicly detailed.

    Josh Waldman's questions to CHARLES RIVER LABORATORIES INTERNATIONAL (CRL) leadership

    Josh Waldman's questions to CHARLES RIVER LABORATORIES INTERNATIONAL (CRL) leadership • Q1 2025

    Question

    Rob Catrol, on for Josh Waldman, asked if the reported growth in small and mid-sized biotech sales was consistent across all three business segments and if there were notable differences between small versus mid-sized biotech performance.

    Answer

    CFO Flavia Pease confirmed the encouraging growth from the overall biotech segment for the second consecutive quarter but stated that the company does not provide a more granular breakdown of performance between its small and mid-sized biotech clients.

    Ask Fintool Equity Research AI